MedoPulse contributor
Source-led editorial research team · Evidence synthesis and public-health reporting
The MedoPulse Evidence Desk prepares plain-language health reporting from regulators, public-health agencies, peer-reviewed journals, trial registries, and clearly attributed institutional sources. The team does not provide individualized medical advice. Items labelled medical review pending have not yet been reviewed by a MedoPulse clinician.
India’s Health Ministry reported more than 80 lakh HPV vaccine doses administered to 14-year-old girls since the national campaign began, while the administrative figures require careful denominator and outcome interpretation.
FDA’s 11 September final order codified class II special controls for software that suggests the likelihood of one cardiovascular condition, while the underlying De Novo classification dates to 2023 and the output is not diagnostic quality.
CDC’s CHAMPS summary reviewed 8,500 deaths in selected African and South Asian catchments, combining tissue sampling, records and expert review.
WHO’s 10 September update records 6,778 confirmed Bundibugyo virus disease cases and 3,269 deaths, while noting surveillance effects and low global risk.
FSIS recalled about 1,513 pounds of specified imported ready-to-eat guanciale after a sample tested positive for Listeria monocytogenes. No illnesses were confirmed at announcement.
A U.S. Embassy travel-health alert reported increased diarrheal illness across Cuba and advised food- and water-safety precautions without providing case counts.
A Pediatrics study found recorded GLP-1 prescribing remained uncommon overall among children aged 8–11 with obesity, while increasing over the study period.
Topline Lp(a)HORIZON results say pelacarsen lowered lipoprotein(a) but did not reduce the study's cardiovascular endpoint in the overall population.
Indian authorities are investigating questioned vials carrying the Abhayrab name and batch number KE25012 after a field sample failed a potency test.
CDC surveillance listed 3,134 confirmed U.S. measles cases for 2026. The figures show outbreak scale, but local death determinations and national reporting remain distinct.